In a statement issued Thursday, the blood-testing company Theranos, which has stretched the adjective “beleaguered” to its very limits, said it would appeal the harsh penalties the Centers for Medicare & Medicaid Services levied on it last month in response to what the agency called life-threatening deficiencies at the company's California lab.
Read Full Article »
